Biotechnology stocks buy

A great thing about living in New York City as an investor is that, sooner or later, almost everyone who is anyone in the financial markets passes through, and often I get to meet to talk over ideas. The annual Jefferies Global Healthcare Conference every June is an example. This year it featured about biotechnology companies.

Biotech is unloved, which makes it a good place for contrarians to bargain-hunt. Net cash flows into the group so far this year are more or less flat. A lot of people look at tech and Silicon Valley as the home turf of innovation and rapid-growth companies like Facebook FB, There are lots of opportunities to do in-depth, fundamental analysis on product launch trends and clinical data events.

Supposedly, Donald Trump was going to change the tax code so that companies could bring cash back home. This was going to spur waves of buyouts by innovation-starved Big Pharma companies hungry for growth.

So far, however, this has been a dub. Alas, Trump is not finished yet.

3 Hot Biotech Stocks to Buy in June - June 1, - seboxinero.web.fc2.com

There will be no draconian crackdown on drug prices in Washington, D. But this is unlikely to happen in any serious way, according to the Jefferies panelists. As this becomes more apparent, investors will get more comfortable with the group and drive up biotech stocks, benefitting anyone who gets in now. Instead, politicians being politicians, they are more likely to go for the low-hanging fruit. Besides, the pharma industry is doing a good job of demonstrating to politicians that drug costs are only a relatively small portion of overall health-care costs.

Biotech is a safe haven from the steam roller of computer-based trading. One big fear in the market now is that artificial intelligence AI deployed by the statistics geniuses will make it difficult for old-school stock pickers, like me, to survive. So far, this has not played out. That may be only temporary. We have to wait and see. But biotech will probably be immune from artificial intelligence, because stock-moving developments in this space are too quirky to model with computers.

It is harder for computers to predict how a company will do the first time it reads out a trial. Big Pharma companies like Sanofi SNY, Their stocks have gone nowhere, or declined, during the past several years. But the Jefferies panel suggested it may be better to take a pass. One reason is the lack of growth. Earnings estimates for the group are the same level now as they were insays Sonderling.

Any blockbusters have a hard time moving the earnings needle because these companies are so big. The more successful they are, the harder it is to replicate that success. They also tend to have bloated overhead. It might biotechnology stocks buy be better to avoid ie proxy automatically detect settings registry and managed-care companies.

Health-care investors have flocked to these names to avoid biotech and pharma stocks that might get hit by drug-price controls.

That trade could reverse vanguard emerging stock market index as worries ease about a drug-pricing australia forex market open time. Here are two big ones to ponder.

Or what if Amazon.

Either change could shift the balance of power in drug pricing away from drug producers. At the time of publication, Michael Brush held INCY. Michael Brush is a Manhattan-based financial writer who publishes the stock theranos stock options Brush Up on Stocks. Brush has covered business for the New York Times and The Economist group.

7 Battered Biotech Stocks to Buy

He attended Columbia Business School in the Knight-Bagehot program. By using this site you agree to the Terms of ServicePrivacy Policyand Cookie Policy.

Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information.

All quotes are in local exchange time. Real-time last sale data for U. Intraday data delayed at least 15 minutes or per exchange requirements. ET Treasury yields travel higher ahead of key housing number.

Breaking Stock market opens slightly higher as Wall Street tries to avoid 2nd straight down day. Updated These stocks may be ready to pick up the bullish baton from techs. Nasdaq Composite up 0. Dow industrials rise 13 points to 21, Breaking Stocks open slightly higher as oil steadies. Ebay launches price matching program. Etsy's stock rallies 0. Etsy job cuts are in addition to layoffs announced in May.

Nationstar to move call center operations back to U. Updated Gold prices rise from 5-week lows as dollar eases. Updated Oil turns slightly higher as traders await fresh U. Home News Viewer Video SectorWatch Podcasts First Take Games Portfolio My MarketWatch. Retirement Retire Here, Not There Encore Taxes How-to Guides Social Security Estate Planning Events Columns Robert Powell's Retirement Portfolio Andrea Coombes's Working Retirement Tools Retirement Planner How long will my money last?

Economy Federal Reserve Capitol Report Economic Report Columns Darrell Delamaide Rex Nutting Tools Economic Calendar. My MarketWatch Watchlist Alerts Games Log In. Five reasons you have to buy biotech stocks now. By Michael Brush Columnist. Biotechnology is an island of innovation in a sluggish economy A lot of people look at tech and Silicon Valley as the home turf of innovation and rapid-growth companies like Facebook FB, Biotech is a safe haven from the steam roller of computer-based trading One big fear in the market now is that artificial intelligence AI deployed by the statistics geniuses will make it difficult for old-school stock pickers, like me, to survive.

Pitfalls to avoid Big Pharma companies like Sanofi SNY, More Coverage These stocks may be ready to pick up the bullish baton from techs This is exactly how much you should tip your Uber driver U.

APR Last Week 6 Months Low Interest We Want to Hear from You Join the conversation Comment. MarketWatch Site Index Topics Help Feedback Newsroom Roster Media Archive Premium Products Mobile. Dow Jones Network WSJ. AstraZeneca PLC ADR U. GlaxoSmithKline PLC ADR U. Roche Holding AG ADR U. Novartis AG ADR U. Walgreens Boots Alliance Inc.